Not a good buy right now for an impatient buyer: the stock is deeply oversold, but still in a clear bearish trend (stacked bearish moving averages) with weak momentum.
A short-term oversold bounce is possible near support (0.777 / 0.75), but without any Intellectia buy signals today, the odds favor choppy/fragile upside rather than a clean reversal.
Options positioning is extremely call-heavy (speculative bullish), but options activity is tiny in absolute volume—sentiment support is not strong enough to override the downtrend.
RSI(6)=17.63: extremely oversold, which can fuel a reflex bounce, but does not by itself confirm a trend reversal.
MACD histogram = -0.00597: still negative (bearish), but contracting (selling pressure easing somewhat).
Key levels: Pivot 0.821 (needs reclaim to improve near-term bias). Support S1 0.777 then S2 0.75. Resistance R1 0.865 and R2 0.892.
Pre-market: 0.8078 (+2.24%) is still below the 0.821 pivot, suggesting the move is a bounce attempt inside a downtrend, not a confirmed breakout.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning: Put/Call OI ratio 0.02 (calls overwhelmingly dominate OI), implying bullish/speculative bias.
Activity: Total volume is very low (3 calls, 0 puts) despite volume vs 30D average being elevated—this is a “thin market” signal, not broad conviction.
Volatility: IV (30D) 197.83 vs historical vol 80.4 = options are pricing very large moves; IV percentile 32 / IV rank 20.8 (not at extremes vs its own history).
Takeaway: Options lean bullish, but participation is too small to treat as strong confirmation.
Technical Summary
Sell
7
Buy
3
Positive Catalysts
increases the probability of a short-term relief bounce.
Neutral/Negative Catalysts
Primary trend remains bearish (SMA stack bearish), and price is still below the pivot (0.821).
Profitability quality concern: gross margin dropped sharply YoY (-46.84% to 9.92%), which can weigh on sentiment even if revenue grows.
No news catalysts in the last week to drive an event-driven re-rating.
No supportive “follow-the-smart-money” signal: no recent congress trading data available; hedge/insider trading trends are neutral (no accumulation signal).
Net income: 2,650,503 (+14,919.57% YoY) — very large YoY jump (likely impacted by base effects), positive but should be viewed alongside margin trends.
EPS: 0.03 (flat YoY as provided).
Gross margin: 9.92% (down -46.84% YoY) — materially weaker unit economics, a key negative trend despite revenue growth.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating/price target change data was provided, suggesting limited visibility from Wall Street coverage in this dataset.
Wall Street-style pros view (based on available fundamentals): strong revenue growth, recent profitability.
Wall Street-style cons view: sharply weaker gross margin, very high volatility/small-cap risk profile, and a technically bearish chart with no proprietary buy signal today.
Wall Street analysts forecast CBAT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CBAT is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast CBAT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CBAT is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
